Suppr超能文献

诊断身材矮小患者垂体发育不全的陷阱。

Pitfalls of diagnosing pituitary hypoplasia in the patients with short stature.

机构信息

Division of Pediatric Endocrinology, Health Sciences University, Istanbul Haseki Training and Research Hospital, Istanbul, Turkey.

Department of Radiology, Celal Bayar University, Faculty of Medicine, Manisa, Turkey.

出版信息

Endocrine. 2024 Oct;86(1):349-357. doi: 10.1007/s12020-024-03951-9. Epub 2024 Jul 5.

Abstract

PURPOSE

Height age (HA) and bone age (BA) delay is well known in the patients with short stature. Therefore assessing pituitary hypoplasia based on chronological age (CA) might cause overdiagnosis of pituitary hypoplasia. We aimed to investigate the diagnostic and prognostic value of the PH and PV based on CA, HA, or BA in the patients with GHD.

METHODS

Fifty-seven patients with severe and 40 patients with partial GHD and 39 patients with ISS assigned to the study. For defining the most accurate diagnosis of pituitary hypoplasia, PH and PV were evaluated based on CA, BA and HA. The relationship of each method with clinical features was examined.

RESULTS

The mean PV was significantly larger in patients with ISS compared to the GH-deficient patients. PV was more correlated with clinical features including height SDS, stimulated GH concentration, IGF-1 and IGFBP-3 SDS, height velocity before and after rGH therapy. We found BA-based PV could discriminate GHD from ISS (Sensitivity: 17%, specificity: 98%, positive predictive value: 94%, negative predictive value: 39%), compared to the other methods based on PH or PV respect to CA and HA. 3% of patients with ISS, 17% of patients with GHD had pituitary hypoplasia based on PV-BA.

CONCLUSION

PV based on BA, has the most accurate diagnostic value for defining pituitary hypoplasia. But it should be kept in mind that there might be still misdiagnosed patients by this method. PV is also a significant predictor for the rGH response.

摘要

目的

身高年龄(HA)和骨龄(BA)延迟在身材矮小的患者中是众所周知的。因此,根据实际年龄(CA)评估垂体发育不全可能导致垂体发育不全的过度诊断。我们旨在研究基于 CA、HA 或 BA 的 PH 和 PV 在 GHD 患者中的诊断和预后价值。

方法

将 57 例严重 GHD 患者、40 例部分 GHD 患者和 39 例 ISS 患者纳入研究。为了更准确地诊断垂体发育不全,我们根据 CA、BA 和 HA 评估 PH 和 PV。检查了每种方法与临床特征的关系。

结果

与 GH 缺乏患者相比,ISS 患者的平均 PV 显著更大。PV 与身高 SDS、刺激 GH 浓度、IGF-1 和 IGFBP-3 SDS、rhGH 治疗前后的身高增长速度等临床特征更相关。我们发现,与基于 PH 或 PV 相对于 CA 和 HA 的其他方法相比,BA 为基础的 PV 能够将 GHD 与 ISS 区分开来(灵敏度:17%,特异性:98%,阳性预测值:94%,阴性预测值:39%)。3%的 ISS 患者和 17%的 GHD 患者根据 PV-BA 存在垂体发育不全。

结论

基于 BA 的 PV 对定义垂体发育不全具有最准确的诊断价值。但应记住,通过这种方法仍可能存在误诊患者。PV 也是 rhGH 反应的重要预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efe/11445333/09e2120f220b/12020_2024_3951_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验